HCPLive

Researchers Identify Features of Serious Pertussis Progression in Infants

 
FRIDAY, Jan. 18 (HealthDay News) -- Rapidly rising white blood cell (WBC) counts and high heart rates and respiratory rates may indicate more serious pertussis progression in infants, according to research published online Jan. 10 in the Journal of the Pediatric Infectious Diseases Society.

Erin L. Murray, Ph.D., from the California Department of Public Health in Richmond, and colleagues reviewed medical records for 31 infants who were ≤90 days of age and hospitalized for pertussis in five Southern California pediatric intensive care units (from Sept. 1, 2009, through June 30, 2011) to obtain demographic and clinical information.

The researchers found that eight of the infants had more severe infections, six had pulmonary hypertension, and four died. Compared with less severe illness, more severe illness was characterized by WBC counts exceeding 30,000, heart rates exceeding 170, and respiratory rates exceeding 70 more rapidly after cough onset.

Our data suggest that a predictor of more severe Bordetella pertussis disease in young infants is an elevated and rapidly rising WBC count, making early and serial WBC count determinations critical to the evaluation of all infants with suspected or proven pertussis," the authors write. "Furthermore, close monitoring of heart and respiratory rates is imperative because these were demonstrated to correlate with more severe disease progression."
 

Abstract
Full Text (subscription or payment may be required)


Copyright © 2013 HealthDay. All rights reserved.
 

Most Popular

Recommended Reading

Natalizumab, a drug typically used to treat multiple sclerosis and Crohn’s disease, has been shown to be effective in treating animal models of HIV.
As good news about new treatments for hepatitis C infections continues to dominate the 2015 International Liver Congress, Texas researchers today reported more success with sofosbuvir and daclatasvir.
Video Interview: Vinood Patel, PhD, PGCHE, fHEA, FRSC, University of Westminster, London, UK, shared valuable insight regarding chronic alcoholic demographics and biomarkers on the horizon at The International Liver Congress 2015.
In this video interview, Camille Barrault, MD, spoke about the implications her work with baclofen could have for the future of liver disease research at The International Liver Congress 2015, Vienna, Austria.
$vAR$